The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Detection of Tuberculosis in HIV-Infected and -Uninfected African Adults Using Whole Blood RNA Expression Signatures: A Case-Control Study
Open accessAbstract
BACKGROUND: A major impediment to tuberculosis control in Africa is the difficulty in diagnosing active tuberculosis (TB), particularly in the context of HIV infection. We hypothesized that a unique host blood RNA transcriptional signature would distinguish TB from other diseases (OD) in HIV-infected and -uninfected patients, and that this could be the basis of a simple diagnostic test. METHODS AND FINDINGS: Adult case-control cohorts were established in South Africa and Malawi of HIV-infected or -uninfected individuals consisting of 584 patients with either TB (confirmed by culture of Mycobacterium tuberculosis [M.TB] from sputum or tissue sample in a patient under investigation for TB), OD (i.e., TB was considered in the differential diagnosis but then excluded), or healthy individuals with latent TB infection (LTBI). Individuals were randomized into training (80%) and test (20%) cohorts. Blood transcriptional profiles were assessed and minimal sets of significantly differentially expressed transcripts distinguishing TB from LTBI and OD were identified in the training cohort. A 27 transcript signature distinguished TB from LTBI and a 44 transcript signature distinguished TB from OD. To evaluate our signatures, we used a novel computational method to calculate a disease risk score (DRS) for each patient. The classification based on this score was first evaluated in the test cohort, and then validated in an independent publically available dataset (GSE19491). In our test cohort, the DRS classified TB from LTBI (sensitivity 95%, 95% CI [87-100]; specificity 90%, 95% CI [80-97]) and TB from OD (sensitivity 93%, 95% CI [83-100]; specificity 88%, 95% CI [74-97]). In the independent validation cohort, TB patients were distinguished both from LTBI individuals (sensitivity 95%, 95% CI [85-100]; specificity 94%, 95% CI [84-100]) and OD patients (sensitivity 100%, 95% CI [100-100]; specificity 96%, 95% CI [93-100]). Limitations of our study include the use of only culture confirmed TB patients, and the potential that TB may have been misdiagnosed in a small proportion of OD patients despite the extensive clinical investigation used to assign each patient to their diagnostic group. CONCLUSIONS: In our study, blood transcriptional signatures distinguished TB from other conditions prevalent in HIV-infected and -uninfected African adults. Our DRS, based on these signatures, could be developed as a test for TB suitable for use in HIV endemic countries. Further evaluation of the performance of the signatures and DRS in prospective populations of patients with symptoms consistent with TB will be needed to define their clinical value under operational conditions. Please see later in the article for the Editors' Summary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Regularization and Variable Selection Via the Elastic Net
Zou, H., & Hastie, T. (2005) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.1467-9868.2005.00503.x · Cited by 20,957
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907847 · Cited by 2,309
Ripley, B. D. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316726 · Cited by 2,241
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., et al. (2010) · Nature · doi:10.1038/nature09247 · Cited by 1,898
Self-citationGlobal Tuberculosis Control 2011, WHO Report 2011
Behera, D. (2012) · The Indian Journal of Medical Research · Cited by 1,022
Boehme, C. C., Nicol, M. P., Nabeta, P., Michael, J. S., Gotuzzo, E., Tahirli, R., Gler, M. T., Blakemore, R., Worodria, W., Gray, C., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60438-8 · Cited by 1,013
HIV and Tuberculosis: a Deadly Human Syndemic
Kwan, C. K., & Ernst, J. D. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-10 · Cited by 720
Nanopore-based detection of circulating microRNAs in lung cancer patients
Wang, Y., Zheng, D., Tan, Q., Wang, M. X., & Gu, L.-Q. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.147 · Cited by 497
Gene expression patterns in blood leukocytes discriminate patients with acute infections
Ramilo, O., Allman, W., Chung, W., Mejias, A., Ardura, M., Glaser, C., Wittkowski, K. M., Piqueras, B., Banchereau, J., Palucka, A. K., et al. (2007) · Blood · doi:10.1182/blood-2006-02-002477 · Cited by 482
Common patterns and disease-related signatures in tuberculosis and sarcoidosis
Maertzdorf, J., Weiner, J., Mollenkopf, H.-J., Network, T., Bauer, T., Prasse, A., Müller-Quernheim, J., Kaufmann, S. H. E., Bellinger, O., Diel, R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121072109 · Cited by 321
Human gene expression profiles of susceptibility and resistance in tuberculosis
Maertzdorf, J., Repsilber, D., Parida, S. K., Stanley, K., Roberts, T., Black, G., Walzl, G., & Kaufmann, S. H. E. (2011) · Genes & Immunity · doi:10.1038/gene.2010.51 · Cited by 304
Facing the Crisis: Improving the Diagnosis of Tuberculosis in the HIV Era
Perkins, M. D., & Cunningham, J. (2007) · The Journal of Infectious Diseases · doi:10.1086/518656 · Cited by 300
Assessing the human immune system through blood transcriptomics
Chaussabel, D., Pascual, V., & Banchereau, J. (2010) · BMC Biology · doi:10.1186/1741-7007-8-84 · Cited by 252
Protease-Triggered Dispersion of Nanoparticle Assemblies
Laromaine, A., Koh, L., Murugesan, M., Ulijn, R. V., & Stevens, M. M. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0706504 · Cited by 251
Jacobsen, M., Repsilber, D., Gutschmidt, A., Neher, A., Feldmann, K., Mollenkopf, H. J., Ziegler, A., & Kaufmann, S. H. E. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0157-6 · Cited by 239
Franken, K. L. M. C., Hiemstra, H. S., van Meijgaarden, K. E., Subronto, Y., den Hartigh, J., Ottenhoff, T. H. M., & Drijfhout, J. W. (2000) · Protein Expression and Purification · doi:10.1006/prep.1999.1162 · Cited by 229
Self-citationAnsari, N. A., Kombe, A. H., Kenyon, T. A., Hone, N. M., Tappero, J. W., NYIRENDA, S., BINKIN, N. J., & Lucas, S. B. (2002) · PubMed · Cited by 205
Functional Correlations of Pathogenesis-Driven Gene Expression Signatures in Tuberculosis
Maertzdorf, J., Ota, M., Repsilber, D., Mollenkopf, H. J., Weiner, J., Hill, P. C., & Kaufmann, S. H. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026938 · Cited by 167
Eldering, E. (2003) · Nucleic Acids Research · doi:10.1093/nar/gng153 · Cited by 162
Wood, R., Maartens, G., & Lombard, C. J. (2000) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200001010-00010 · Cited by 154
Gene‐Expression Patterns in Whole Blood Identify Subjects at Risk for Recurrent Tuberculosis
Mistry, R. A., Cliff, J. M., Clayton, C. L., Beyers, N., Mohamed, Y. S., Wilson, P. A., Dockrell, H. M., Wallace, D., van Helden, P. D., Duncan, K., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/510397 · Cited by 145
Self-citationLowe, S. B., Dick, J. A. G., Cohen, B. E., & Stevens, M. M. (2011) · ACS Nano · doi:10.1021/nn204361s · Cited by 145
Cox, J. A., Lukande, R. L., Lucas, S. B., Nelson, A. M., Van Marck, E., & Colebunders, R. (2010) · PubMed · Cited by 117
Lawn, S. D., & Wood, R. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir411 · Cited by 112
Aabye, M. G., Ravn, P., PrayGod, G., Jeremiah, K., Mugomela, A., Jepsen, M., Faurholt‐Jepsen, D., Range, N. S., Friis, H., Changalucha, J. M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004220 · Cited by 105
Lu, C., Wu, J., Wang, H., Wang, S., Diao, N., Wang, F., Gao, Y., Chen, J., Shao, L., Weng, X., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024290 · Cited by 104
Identification of biomarkers for tuberculosis disease using a novel dual-color RT–MLPA assay
Joosten, S. A., Goeman, J. J., Sutherland, J. S., Opmeer, L., de Boer, K. G., Jacobsen, M., Kaufmann, S. H. E., Finos, L., Magis-Escurra, C., Ota, M. O. C., et al. (2011) · Genes and Immunity · doi:10.1038/gene.2011.64 · Cited by 99
Self-citationChamie, G., Luetkemeyer, A. F., Walusimbi, M., Okwera, A., Whalen, C. C., Mugerwa, M., Havlir, D. V., & Charlebois, E. D. (2010) · PubMed · Cited by 74
Transcriptional responses of host peripheral blood cells to tuberculosis infection
Lesho, E. P., Forestiero, F., Hirata, M. H., Hirata, R. D. C., Cecon, L., de Melo, F. A. F., Paik, S. H., Murata, Y., Ferguson, E. W., Wang, Z., et al. (2011) · Tuberculosis · doi:10.1016/j.tube.2011.07.002 · Cited by 68
Cox, J. A., Lukande, R. L., Lucas, S., et al. (2010) · Research Portal (King's College London) · Cited by 66
Kranzer, K., van Schaik, N., Karmue, U., Middelkoop, K., Sebastian, E., Lawn, S. D., Wood, R., & Bekker, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025244 · Cited by 55
Crampin, A. C., Floyd, S., Mwaungulu, F., et al. (2001) · PubMed · Cited by 54
Self-citationUndiagnosed pulmonary tuberculosis deaths in rural South Africa.
Pronyk, P. M., Kahn, K., Hargreaves, J., Tollman, S. M., Collinson, M. A., Häusler, H. P., & Porter, J. (2004) · PubMed · Cited by 30
Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms
Rangaka, M. X., Gideon, H. P., Wilkinson, K. A., Pai, M., Mwansa-Kambafwile, J. R. M., Maartens, G., Glynn, J. R., Boulle, A., Fielding, K., Goliath, R. T., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00058911 · Cited by 28
Self-citationLaboratories, M. (2002) · Cited by 25
Cited by
A blood RNA signature for tuberculosis disease risk: a prospective cohort study
Zak, D. E., Penn-Nicholson, A., Scriba, T. J., Thompson, E., Suliman, S., Amon, L. M., Mahomed, H., Erasmus, M., Whatney, W., Hussey, G. D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01316-1 · Cited by 780
Self-citationDrain, P. K., Bajema, K. L., Dowdy, D., Dheda, K., Naidoo, K., Schumacher, S. G., Ma, S., Meermeier, E., Lewinsohn, D. M., & Sherman, D. R. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00021-18 · Cited by 565
Genome-wide expression for diagnosis of pulmonary tuberculosis: a multicohort analysis
Sweeney, T. E., Braviak, L., Tato, C. M., & Khatri, P. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)00048-5 · Cited by 445
Diagnosis of Childhood Tuberculosis and Host RNA Expression in Africa
Anderson, S. T., Kaforou, M., Brent, A. J., Wright, V. J., Banwell, C. M., Chagaluka, G., Crampin, A. C., Dockrell, H. M., French, N., Hamilton, M. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1303657 · Cited by 379
Self-citationTuberculosis: advances and challenges in development of new diagnostics and biomarkers
Walzl, G., McNerney, R., du Plessis, N., Bates, M., McHugh, T. D., Chegou, N. N., & Zumla, A. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30111-7 · Cited by 341
Metadata
- Authors
- Kaforou, M., Wright, V. J., Oni, T., French, N., Anderson, S. T., Bangani, N., Banwell, C. M., Brent, A. J., Crampin, A. C., Dockrell, H. M., Eley, B., Heyderman, R. S., Hibberd, M. L., Kern, F., Langford, P. R., Ling, L., Mendelson, M., Ottenhoff, T. H., Zgambo, F., Wilkinson, R. J., Coin, L. J., & Levin, M.
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-10-22
- Volume
- 10
- Issue
- 10
- Pages
- e1001538
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2102152191
- Cited by
- 371
- References
- 37
- FWCI
- 17.73
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.